Gene therapy for induction of immunological tolerance in organ allografts
诱导同种异体器官移植免疫耐受的基因治疗
基本信息
- 批准号:13671253
- 负责人:
- 金额:$ 2.24万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2001
- 资助国家:日本
- 起止时间:2001 至 2002
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
(Background) Gene transfer approach has the potential to introduce immunosuppressive molecules directly into the allograft, which in turn should limit systemic side effects of conventional immunosuppressive therapy to recipients. (Aim) To analyze the efficacy and putative mechanisms of adenoviral-mediated IL4 gene transfer in rat kidney transplant model. (Material & Method) Renal allografts (BN rat) were perfused in-situ with Adex1CAmIL4 or AxCALacZ (RIKEN DNA Bank, respectively) incubated at 4C for 1.5, 24, 48, 72h (ex-vivo), or/and transplanted to LEW recipients. Adenovirus vector was perfused with 4C saline or UW solution, and renal grafts were preserved in 4C saline (1.5h) or UW solution (24-72h). (Results) 1. β-gal was detected after 24h preservation, but not 1.5h in ex-vivo model. After transplantation, there was mo staining of β-gal in renal allograft at day2/day7. 2. In ex-vivo preservation, IL4 was expressed in all of renal grafts (1.5h-72h) with Adex1CAmIL4 perfusion, even though it was not detected in control group perfused with cold saline in any preserved term. 3. Histological damage of renal allografts maintained for 24h after Adex1CAmIL4 gene transfer were diminished as compared with 1.5h preserved grafts at day7 after transplantation. (Conclusion) 24h preservation was prefer to induce immunosuppressive effects of Adenovirus-mediated IL4 gene therapy as compared. with 1.5h maintaining. It seems that appropriate expression of IL4 might be important at the early phase (day0-2) after transplantation. Further study will be necessary to inquire "optimal way" of gene transfer in transplant setting.
(背景)基因转移方法具有将免疫抑制分子直接引入同种异体移植物的潜力,这反过来又可以限制常规免疫抑制治疗对受者的全身副作用。(Aim)目的探讨腺病毒介导的白细胞介素4(IL 4)基因转移在大鼠肾移植模型中的作用及可能机制。(材料与方法)用Adex 1CAmIL 4或AxCALacZ(分别为RIKEN DNA Bank)原位灌注肾移植物(BN大鼠),在4 ℃下孵育1.5、24、48、72小时(离体),或/和移植到LEW受体。将腺病毒载体分别用4C生理盐水或UW液灌注,移植肾保存于4C生理盐水(1.5h)或UW液(24- 72 h)中。(结果)1.离体模型保存24 h后可检测到β-gal,而保存1.5h后未检测到。移植后第2天/第7天,移植肾组织中β-gal染色消失。2.在离体保存过程中,经Adex 1CAmIL 4灌注的移植肾在1.5h-72 h内均有IL 4的表达,而对照组在任何保存期均未检测到IL 4的表达。3.移植后第7天,Adex 1CAmIL 4基因转染后24 h的移植肾组织损伤较保存1.5h的移植肾明显减轻。(结论)与腺病毒介导的IL 4基因治疗相比,保存24 h更有利于诱导免疫抑制效应。维持1.5h。IL 4的适当表达在移植后早期(0 -2天)可能是重要的。今后的研究还需进一步探索移植背景下基因转移的“最佳途径”。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KATO Hirohisa其他文献
KATO Hirohisa的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KATO Hirohisa', 18)}}的其他基金
Identification and characterization of biofilm regulatory autolysins
生物膜调节自溶素的鉴定和表征
- 批准号:
23592746 - 财政年份:2011
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of novel drugs to control oral biofilms towards clinical application
开发控制口腔生物膜的新药并走向临床应用
- 批准号:
20592181 - 财政年份:2008
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Vasculitis in Kawasaki disease : the molecular and vascular biological studies
川崎病的血管炎:分子和血管生物学研究
- 批准号:
10470183 - 财政年份:1998
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
Comparative study on Kawasaki disease between Japan and North America
日本与北美川崎病的比较研究
- 批准号:
09044347 - 财政年份:1997
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for international Scientific Research
Development of the new transctaneous occlusion system for patent ductus arteriosus
新型经皮动脉导管未闭封堵系统的开发
- 批准号:
08557053 - 财政年份:1996
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Study on Etiology and Pathogenesis of Kawasaki Disease
川崎病病因及发病机制研究
- 批准号:
07307011 - 财政年份:1995
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Investigation of cause of Kawasaki disease, molecular infecto-immunolgical analysis
川崎病病因调查、分子感染免疫学分析
- 批准号:
06454310 - 财政年份:1994
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
cDNA cloning of the recepters for the members of TGFbeta superfamily
TGFbeta超家族成员受体的cDNA克隆
- 批准号:
05671566 - 财政年份:1993
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Morphological and hemodynamic changes of the fetal heart : chronological evaluation from fetus to newborn
胎儿心脏的形态和血流动力学变化:从胎儿到新生儿的时间顺序评估
- 批准号:
04670627 - 财政年份:1992
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
Modulating Immunity to Nucleic Acids and Inducing Tolerance by Gene Transfer
通过基因转移调节核酸免疫并诱导耐受
- 批准号:
8886697 - 财政年份:2015
- 资助金额:
$ 2.24万 - 项目类别:
Modulating Immunity to Nucleic Acids and Inducing Tolerance by Gene Transfer
通过基因转移调节核酸免疫并诱导耐受
- 批准号:
8990805 - 财政年份:2015
- 资助金额:
$ 2.24万 - 项目类别:
Modulating Immunity to Nucleic Acids and Inducing Tolerance by Gene Transfer
通过基因转移调节核酸免疫并诱导耐受
- 批准号:
9189586 - 财政年份:2015
- 资助金额:
$ 2.24万 - 项目类别:
Inducing Tolerance to Gene Transfer in Dystrophic Mice
诱导营养不良小鼠对基因转移的耐受性
- 批准号:
7408714 - 财政年份:2008
- 资助金额:
$ 2.24万 - 项目类别:
Inducing Tolerance to Gene Transfer in Dystrophic Mice
诱导营养不良小鼠对基因转移的耐受性
- 批准号:
7614179 - 财政年份:2008
- 资助金额:
$ 2.24万 - 项目类别:
Inducing Tolerance to Gene Transfer in Dystrophic Mice
诱导营养不良小鼠对基因转移的耐受性
- 批准号:
7810630 - 财政年份:2008
- 资助金额:
$ 2.24万 - 项目类别:
Research for immuno-logical tolerance induction in islet xeno-transplantation -Therapeutic effect of a adenovirus or retrovirus mediated CTLA4Ig gene transfer combined with immunosuppressive regents-
胰岛异种移植中免疫耐受诱导的研究-腺病毒或逆转录病毒介导的CTLA4Ig基因转移联合免疫抑制药物的治疗效果-
- 批准号:
13671233 - 财政年份:2001
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
OPIOID RECEPTOR GENE TRANSFER-PAIN AND TOLERANCE
阿片受体基因转移-疼痛和耐受性
- 批准号:
6405267 - 财政年份:2001
- 资助金额:
$ 2.24万 - 项目类别:
OPIOID RECEPTOR GENE TRANSFER-PAIN AND TOLERANCE
阿片受体基因转移-疼痛和耐受性
- 批准号:
6643572 - 财政年份:2001
- 资助金额:
$ 2.24万 - 项目类别:
OPIOID RECEPTOR GENE TRANSFER-PAIN AND TOLERANCE
阿片受体基因转移-疼痛和耐受性
- 批准号:
6786791 - 财政年份:2001
- 资助金额:
$ 2.24万 - 项目类别: